Ethnic variation in the incidence of ALS: a systematic review
- PMID: 17389304
- DOI: 10.1212/01.wnl.0000258551.96893.6f
Ethnic variation in the incidence of ALS: a systematic review
Abstract
Background: The findings of recent genetic polymorphism studies in ALS suggest that the influence of genetic risk factors for the disease may vary by ethnicity. It is now widely accepted that the incidence of ALS is uniform across Caucasian populations, but whether racial variation across other ethnicities exists remains unknown.
Method: Systematic review of the known literature on the incidence, prevalence, and mortality of ALS across all ethnicities. To facilitate comparison, studies were grouped according to the type of data presented and examined for sources of case ascertainment and inclusion criteria.
Results: The literature search identified 61 publications. Lower standardized incidence rates were observed in Asian than Caucasian populations. Within the United States, several incidence and mortality studies have identified lower ALS frequency among African American and Hispanic populations than among non-Hispanic Caucasians. These observations are supported by the other data sources.
Conclusions: The incidence of ALS may be lower among African, Asian, and Hispanic ethnicities than among whites. We conclude with proposals for a prospective epidemiologic study concentrating on non-Caucasian populations.
Comment in
-
Ethnic variation in the incidence of ALS: a systematic review.Neurology. 2007 Aug 14;69(7):711; author reply 711-2. doi: 10.1212/01.wnl.0000285431.01005.67. Neurology. 2007. PMID: 17698801 No abstract available.
Similar articles
-
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1. MMWR Surveill Summ. 2025. PMID: 40493548 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence.Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD014963. doi: 10.1002/14651858.CD014963.pub2. Cochrane Database Syst Rev. 2022. PMID: 36385229 Free PMC article.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
Cited by
-
Results of Florida's Amyotrophic Lateral Sclerosis Surveillance Project, 2009-2011.BMJ Open. 2015 Apr 21;5(4):e007359. doi: 10.1136/bmjopen-2014-007359. BMJ Open. 2015. PMID: 25900464 Free PMC article.
-
Creatine Kinase and Progression Rate in Amyotrophic Lateral Sclerosis.Cells. 2020 May 8;9(5):1174. doi: 10.3390/cells9051174. Cells. 2020. PMID: 32397320 Free PMC article.
-
An overview on amyotrophic lateral sclerosis and cadmium.Neurol Sci. 2021 Feb;42(2):531-537. doi: 10.1007/s10072-020-04957-7. Epub 2020 Dec 5. Neurol Sci. 2021. PMID: 33280067 Free PMC article. Review.
-
Incidence of amyotrophic lateral sclerosis in Europe.J Neurol Neurosurg Psychiatry. 2010 Apr;81(4):385-90. doi: 10.1136/jnnp.2009.183525. Epub 2009 Aug 25. J Neurol Neurosurg Psychiatry. 2010. PMID: 19710046 Free PMC article.
-
Scientific Rigor Recommendations for Optimizing the Clinical Applicability of Translational Research.J Neurol Neurophysiol. 2012;3:e111. doi: 10.4172/2155-9562.1000e111. J Neurol Neurophysiol. 2012. PMID: 24490120 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous